Three Dead From Hantavirus Outbreak

A severe hantavirus outbreak has claimed the lives of three individuals aboard the cruise ship MV Hondius, prompting a global health investigation and raising concerns about potential human-to-human transmission of the rare but deadly virus. As of May 8, 2026, eight cases, including three deaths, have been reported among passengers and crew. The ship, which was on a polar cruise from Argentina to Antarctica, is currently off the coast of Cape Verde, where authorities have denied it permission to dock due to public health concerns.

The outbreak, which began with illnesses appearing between April 6 and April 28, 2026, has been characterized by a rapid progression from initial flu-like symptoms to severe respiratory distress, pneumonia, and shock. Two of the confirmed cases have been identified as the Andes strain of hantavirus, a variant known for its potential, albeit rare, ability to spread between people. This strain, endemic to South America, carries a mortality rate of up to 50%.

The World Health Organization (WHO) is leading the investigation into the origins of the outbreak, with a particular focus on how the virus may have spread within the confined environment of the cruise ship. Two symptomatic passengers and one previously suspected case were flown to the Netherlands on May 6 and 7 as part of medical evacuations.

Hantavirus infections, while rare globally, can be severe and life-threatening. Symptoms typically appear one to eight weeks after exposure and begin with flu-like manifestations such as fever, chills, muscle aches, headaches, nausea, vomiting, and diarrhea. In more severe cases, particularly with hantavirus pulmonary syndrome (HPS), the illness progresses rapidly to include coughing and shortness of breath, potentially leading to acute respiratory distress syndrome, fluid accumulation in the lungs, organ failure, and death. The case fatality rate for hantavirus infections varies by region and strain, ranging from less than 1% to 15% in Asia and Europe, and up to 50% in the Americas.

There is no specific cure or vaccine for hantavirus. Treatment focuses on supportive care, including oxygen therapy, fluid management, and intensive monitoring in an intensive care unit (ICU) for severe cases. Early detection and prompt medical attention are critical for improving survival rates.

The primary mode of transmission for hantaviruses is through inhalation of aerosolized virus particles shed in the urine, feces, and saliva of infected rodents, such as mice and rats. While human-to-human transmission is uncommon, the Andes strain's capacity for such spread is a significant factor in this outbreak. Prevention strategies revolve around avoiding contact with rodents and their excreta, and safe cleanup practices when dealing with potential rodent contamination. This includes ventilating enclosed spaces before cleaning, wearing appropriate respiratory protection (such as N95 masks), and using disinfectants to clean contaminated areas.

The first recognized outbreak of hantavirus pulmonary syndrome in the United States occurred in 1993 in the Four Corners region, leading to the identification of the Sin Nombre virus. Since then, national surveillance has been conducted, with 890 laboratory-confirmed cases reported in the U.S. by the end of 2023. The current outbreak on the MV Hondius underscores the potential for hantavirus to emerge in unexpected settings and highlights the importance of continued vigilance and international cooperation in managing infectious disease threats.